← Back to Search

Phototherapy

Luma Light System for Psoriasis

N/A
Waitlist Available
Research Sponsored by Illumicure Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2, 4, 22 and 30 weeks
Awards & highlights

Study Summary

This is a proof of concept, investigator blinded study to evaluate the efficacy and safety of a novel combination of a home narrow band ultraviolet B (NBUVB) lamp with an occlusive dressing in adult subjects with mild to moderate psoriasis vulgaris. Two interpatient arms will be used to compare the efficacy of combination of NBUVB with an occlusive dressing (active) to no treatment (control). 32 patients will be enrolled in this 30 week study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2, 4, 22 and 30 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2, 4, 22 and 30 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Target Plaque Assessment (TPA) at 6 weeks
Secondary outcome measures
Compliance
Duration of remission
Frequency and severity of device and / or procedure related adverse events
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Luma Light SystemExperimental Treatment1 Intervention
The experimental arm will be a combination of an occlusive dressing and NBUVB light.
Group II: Non-treatment ControlActive Control1 Intervention
Control arm will not have any intervention

Find a Location

Who is running the clinical trial?

Illumicure IncLead Sponsor
1 Previous Clinical Trials
10 Total Patients Enrolled
1 Trials studying Psoriasis
10 Patients Enrolled for Psoriasis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Evaluation of Efficacy, Duration of Remission and Safety of a Light and Occlusive Patch Therapy for Plaque Psoriasis
2016. "Evaluation of Efficacy, Duration of Remission and Safety of a Light and Occlusive Patch Therapy for Plaque Psoriasis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03180866.
All > Psoriasis > Plaque Psoriasis
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top